This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Alcides Chaux: Innovator in Cancer Diagnostics
Introduction
Alcides Chaux is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of diagnostics. His innovative work focuses on methods that can aid in the early detection and prediction of cancer in patients.
Latest Patents
Alcides Chaux holds a patent for his invention titled "5-hydroxymethylcytosine in human cancer." This patent outlines a method for diagnosing or predicting cancer in patients. The process involves several steps, including the preparation of patient tissue samples, antigen retrieval, and the use of specific affinity reagents to detect levels of 5-hydroxymethylcytosine (5hmC). The method ultimately identifies patients as having cancer based on the quantification of 5hmC levels compared to a control.
Career Highlights
Chaux is affiliated with Johns Hopkins University, where he continues to advance research in cancer diagnostics. His work is pivotal in developing new methodologies that can potentially improve patient outcomes through early detection.
Collaborations
Alcides Chaux has collaborated with esteemed colleagues such as Michael Christoph Haffner and Angelo M DeMarzo. These partnerships enhance the research efforts and contribute to the innovative environment at Johns Hopkins University.
Conclusion
Alcides Chaux is a prominent figure in cancer research, with a focus on innovative diagnostic methods. His contributions through patents and collaborations are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile